Rafal Dabrowski

TL;DR: Angina does not predict all-cause mortality in medically treated patients with LV systolic dysfunction and CAD, nor does it identify patients who have a greater survival benefit from CABG, however, CABg does improve angina to a greater extent than medical therapy alone.

TL;DR: The characteristics and clinical outcomes of patients with and without DM randomized to CABG and MED or MED alone were compared in this paper, where patients with DM had more triple vessel CAD, higher LVEF, and smaller left ventricular volumes.

TL;DR: The interaction between the burden of medical co‐morbidities and the benefit from surgical revascularization has not been previously described in patients with ischaemic cardiomyopathy.

TL;DR: In this article, the authors determined the possible relationship between coronary artery bypass grafting and optimal medical therapy and its effect on the outcomes of patients with ischemic cardiomyopathy.

TL;DR: LVESVI and E/A ratio were stronger predictors of prognosis than New York Heart Association functional class, anemia, diabetes, history of atrial fibrillation, and stroke and should be considered as standard in assessing risks in ischemic heart failure.